Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes

Insights into Imaging

Table 3 Laboratory outcome of PSE in three groups

	Group 1 (n = 65)	Group 2 (n = 58)	Group 3 (n = 56)	p value
WBCs (× 10⁹/L)
Preprocedural	2.4 ± 0.8	2.59 ± 0.42	2.5 ± 0.6	0.361
After 2 week	7.1 ± 0.9	7.73 ± 1.92	7.5 ± 1.7	0.047*
After 1 month	5.2 ± 0.7	5.89 ± 1.09	5.6 ± 1.2	0.001*
After 6 months	4.8 ± 0.8	5.36 ± 1.23	5.5 ± 1.3	0.002*
After 1 year	4.3 ± 0.5	4.89 ± 0.97	4.7 ± 1.1	0.001*
Platelet (× 10⁹/L)
Preprocedural	43.6 ± 8.9	42.2 ± 11.1	44.21 ± 8.5	0.504
After 2 week	141.2 ± 19.9	155 ± 33.2	155.56 ± 30.7	0.006*
After 1 month	118.8 ± 13.2	127.1 ± 21	126.23 ± 24.4	0.036*
After 6 months	102.6 ± 10	112.3 ± 18.5	110.79 ± 20.3	0.002*
After 1 year	95 ± 11.8	105.8 ± 19.8	105.62 ± 18.9	0.0004*

Data represent the mean ± SD
Group 1—Gelfoam group, Group 2—Embosphere microspheres group, Group 3—polyvinyl alcohol
PSE—partial splenic embolization, WBCs—white blood cells, SD—standard deviation
*Significant